Aurora Spine Corp (OTCPK:ASAPF)

Q4 2025 Aurora Spine Corp Earnings Call Transcript

Apr 30, 2026 / 03:00 PM GMT

Release Date Price: $0.19709 (+1.07%)

Transcript

Key Points

Positve

Aurora Spine Corp (ASAPF) achieved record revenues in fiscal 2025, including the first $5 million revenue quarter in the company's history.
The company reported a 14% increase in total revenues for Q4 2025 compared to the previous quarter, driven by strong sales of ZIP implants and SiFusion devices.
Gross profit margin improved to 62.4% in Q4 2025, up from 57.8% in Q4 2024, due to increased sales of higher-margin implants and lower distributor commissions.
Aurora Spine Corp (ASAPF) successfully expanded its sales team, adding new personnel and covering previously uncovered territories, which contributed to revenue growth.
The launch of the DEXA-L product, part of Aurora's patented DEXA technology platform, is expected to be a key growth catalyst in 2026, targeting a large market of patients with low bone mass.

Negative

Despite achieving record revenues, Aurora Spine Corp (ASAPF) reported a net loss of $41,000 for Q4 2025, although this was an improvement from a $653,000 loss in Q4 2024.
Operating expenses for fiscal 2025 increased slightly to $11.8 million from $11.5 million in fiscal 2024, indicating ongoing cost pressures.
The company is facing contractual issues with a vendor related to the TFX product, which are still under discussion and could impact future sales.
Aurora Spine Corp (ASAPF) has not yet achieved consistent cash flow positivity, with seasonality affecting revenue patterns, particularly at the start of the year.
The timeline for resuming sales of the facet implant is uncertain, pending discussions with the FDA, which could delay potential revenue from this product.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ASG.V - Aurora Spine Corp
Q4 2025 Aurora Spine Corp Earnings Call
Apr 30, 2026 / 03:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and welcome to the Aurora Spine Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero.

After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press then one on your touch-tone phone. To withdraw your question, please press then two. Please note this event is being recorded. I would now like to turn the conference over to Adam Lowensteiner of Lithon Partners. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.